Promising Findings from Aspen Neuroscience's ASPIRO Clinical Trial for Parkinson's Disease Aspen Neuroscience presents positive results from its ASPIRO trial at the AD/PD 2026 conference, showing significant benefits for Parkinson's patients.

Promising Findings from Aspen Neuroscience's ASPIRO Clinical Trial for Parkinson's Disease #USA #San_Diego #Parkinson's_Disease #Aspen_Neuroscience #Sasineprocel

Aspen Neuroscience's Sasineprocel Paves the Way for Innovative Parkinson's Treatment Discover how Aspen Neuroscience's Sasineprocel is set to revolutionize Parkinson's treatment by using a patient's own cells, eliminating immune suppression.

Aspen Neuroscience's Sasineprocel Paves the Way for Innovative Parkinson's Treatment #United_States #San_Diego #Parkinson's_Disease #Aspen_Neuroscience #Sasineprocel